GREAT STOCKS UNDER $15 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : GREAT STOCKS UNDER $15

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bo Didley who wrote (107)	12/9/1998 11:52:00 PM
From: David K.	Read Replies (1) of 126

The idea sounds great. However, isn't the company talking about a possibility rather than a reality? "........ the studies begin to demonstrate the POTENTIAL clinical benefits of the AastromReplicell(TM) System as we approach European market introduction of the product line for stem cell therapy. These POTENTIAL benefits include improving patient care and enabling transplants to be performed when they otherwise might not have been feasible." Chief Executive Douglas Armstrong said, ''The pivotal trial represents an extension of the earlier trial ... We BELIEVE the subsequent trial results will further demonstrate the clinical utility of the AastromReplicell System.'' God willing, we all hope that they will be completely successful in their endeavors. At the moment, it appears to be at the PR stage. Ride it up on the enthusiasm and take your profits before it goes back down (i.e if the enthusiasm continues for a few more days)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next